参考文献/References:
[1] 赵芳芳, 郭红, 陈嘉. LncRNA TUG1 在甲状腺癌组织中的表达及其对细胞增殖和迁移的影响[J]. 现代检验医学杂志, 2020, 35(6): 42-47. ZHAO Fangfang, GUO Hong, CHEN Jia. Expression of LncRNA TUG1 in thyroid carcinoma tissues and its effect on cell proliferation and migration[J]. Journal of Modern Laboratory Medicine, 2020, 35(6): 42-47.
[2] 李玉平, 王伦善. 血清TSH,TPOAb 和TGAb 水平在良恶性甲状腺结节中的鉴别诊断价值[J]. 现代检验医学杂志, 2019, 34(5): 93-97. LI Yuping, WANG Lunshan. Diagnostic value of thyroid autoantibodies and tsh in thyroid nodules[J]. Journal of Modern Laboratory Medicine, 2019, 34(5):93-97.
[3] 赵白信, 于慧娟, 焦方杰, 等. 彩色多普勒超声联合血清glactin-3,HMGB-1 和TSGF 水平检测在甲状腺腺瘤诊断中的临床意义[J]. 现代检验医学杂志,2021, 36(4): 87-92. ZHAO Baixin, YU Huijuan, JIAO Fangjie, et al. Clinical significance of color doppler ultrasound combined with serum glactin-3, HMGB-1 and TSGF levels in the diagnosis of thyroid adenoma[J]. Journal of Modern Laboratory Medicine, 2021, 36(4): 87-92.
[4] FAN Yaohua, LI Yan, ZHU Yuzhang, et al. MiR-301b-3p regulates breast cancer cell proliferation, migration, and invasion by targeting NR3C2[J].Journal of Oncology, 2021, 2021: 8810517.
[5] ZHAO Zhijian, ZHANG Mengping, DUAN Xiaolu, et al. Low NR3C2 levels correlate with aggressive features and poor prognosis in non-distant metastatic clear-cell renal cell carcinoma[J]. Journal of Cellular Physiology, 2018, 233(10): 6825-6838.
[6] ZHANG Zhengliang, CHE Xiangming, YANG Ni, et al. MiR-135b-5p promotes migration, invasion and EMT of pancreatic cancer cells by targeting NR3C2[J]. Biomedicine & Pharmacotherapy, 2017, 96: 1341-1348.
[7] KIM E J, KIM J S, LEE S, et al. ZEB1-regulated lnc-Nr2f1 promotes the migration and invasion of lung adenocarcinoma cells[J]. Cancer Letters, 2022, 533:215601.
[8] 张倩, 段婷婷, 任玉宝. 结直肠癌组织中PLOD2,ZEB1 表达变化及意义[J]. 山东医药, 2022, 62(10):67-70. ZHANG Qian, DUAN Tingting, REN Yubao. Changes and significance of PLOD2 and ZEB1 expression in colorectal cancer[J]. Shandong Medical Journal, 2022, 62(10): 67-70.
[9] 刘建宇, 薛栋, 高立科. 锌指E 盒结合蛋白1 在恶性肿瘤中的研究进展[J]. 中国现代普通外科进展,2022, 25(5): 377-380. LIU Jianyu, XUE Dong, GAO Like. Research progress of Zinc finger E-box binding protein 1 in malignant tumors[J]. Chinese Journal of Current Advances in General Surgery, 2022, 25(5): 377-380.
[10] 王玲, 王健, 赵寅生, 等. 甲状腺乳头状癌患者血清促甲状腺激素水平和组织促甲状腺激素受体检测的临床应用价值[J]. 现代检验医学杂志, 2021, 36(1):61-64. WANG Ling, WANG Jian, ZHAO Yinsheng, et al. Clinical application value of serum thyrotropin level and tissue thyrotropin receptor detection in patients with thyroid papillary carcinoma[J]. Journal of Modern Laboratory Medicine, 2021, 36(1): 61-64.
[11] 宋创业, 严丽, 孟艳林, 等. 甲状腺癌发生发展及预后的相关影响因素[J]. 中华普通外科学文献(电子版), 2020, 14(1): 72-75. SONG Chuangye, YAN Li, MENG Yanlin, et al. Related factors of occurrence, development and prognosis of thyroid cancer[J]. Chinese Archives of General Surgery(Electronic Edition), 2020, 14(1): 72-75.
[12] PRETE A, DE SOUZA P B, CENSI S, et al. Update on fundamental mechanisms of thyroid cancer[J]. Frontiers in Endocrinology, 2020, 11:102.
[13] WANG Chao, HU Fengyun. Long noncoding RNA SOX2OT silencing alleviates cerebral ischemiareperfusion injury via miR-135a-5p-mediated NR3C2 inhibition[J]. Brain Res Bull, 2021, 173:193-202.
[14] GUO Jingyu, WANG Yukun, L? Bo, et al. MiR-454 performs tumor-promoting effects in oral squamous cell carcinoma via reducing NR3C2[J]. Journal of Oral Pathology & Medicine, 2020, 49(4): 286-293.
[15] YUAN Fan, YUAN Ruixue, REN Decheng, et al. A novel NR3C2 polymorphism and the increased thyroidstimulating hormone concentration are associated with venlafaxine treatment outcome in Chinese Han MDD patients[J]. Psychiatry Research, 2020, 284: 112690.
[16] 卢达新, 高艳霞, 于丽凤, 等. 微小RNA hsa-mir-301b 对乳腺癌细胞增殖能力的影响研究[J]. 中国实用内科杂志, 2021, 41(2): 141-145. LU Daxin, GAO Yanxia, YU Lifeng, et al. Effect of microRNA hsa-mir-301b on proliferation of breast cancer cells[J]. Chinese Journal of Practical Internal Medicine, 2021, 41(2): 141-145.
[17] 陈恩更, 陈力, 曹高扬, 等. 基于免疫基因组学的结肠腺癌患者预后风险模型的建立[J]. 解放军医学杂志, 2020, 45(9): 935-939. CHEN Engeng, CHEN Li, CAO Gaoyang, et al. Construction of prognostic risk model for patients with colon adenocarcinoma based on immunogenomics analysis[J]. Medical Journal of Chinese People’s Liberation Army, 2020, 45(9): 935-939.
[18] 柳家荣, 张琪. ZEB1 基因在甲状腺乳头状癌诊断中的意义及对细胞上皮- 间质转化的影响[J]. 实用癌症杂志, 2022, 37(8): 1224-1228. LIU Jiarong, ZHANG Qi. Significance of ZEB1 gene in diagnosis and differentiation of papillary thyroid carcinoma and its influence on cell epithelialmesenchymal transition[J]. The Practical Journal of Cancer, 2022, 37(8): 1224-1228.
[19] 钟淙, 石琴, 章超. LncRNA MALAT1 调控miR-144-3p/ZEB1 对肺癌放射敏感性的影响[J]. 实用肿瘤杂志, 2022, 37(4): 307-314. ZHONG Cong, SHI Qin, ZHANG Chao. Effect of LncRNA MALAT1 regulating miR-144-3p/ZEB1 on radiosensitivity of lung cancer[J]. Journal of Practical Oncology, 2022, 37(4): 307-314.
[20] 张道宝, 徐建国. MiR-200 家族及侵袭相关基因ZEB1, ZEB2 和CTNNB1 在颅咽管瘤组织中的表达及意义[J]. 临床神经外科杂志, 2022, 19(2): 167-170. ZHANG Daobao, XU Jianguo. Expression and significance of miR-200 family and invasion-related genes ZEB1,ZEB2 and CTNB1 in craniopharyngioma[J]. Journal of Clinical Neurosurgery, 2022, 19(2): 167-170.
[21] 黄丽群, 谢龙, 张冠杰, 等. 白藜芦醇下调E 盒结合锌指蛋白1 表达对甲状腺癌细胞侵袭、迁移的影响[J]. 中国临床药理学杂志, 2021, 37(15): 2035-2038. HUANG Liqun, XIE Long, ZHANG Guanjie, et al. Effects of resveratrol on the invasion and migration of thyroid cancer cells by down regulating the expression of E-box binding Zinc finger protein 1[J]. The Chinese Journal of Clinical Pharmacology, 2021, 37(15): 2035-2038.
相似文献/References:
[1]彭继英a,杨红杰b,石晓欣a,等.细针穿刺细胞学检查在甲状腺癌碘-131 治疗后复发诊断中的应用价值[J].现代检验医学杂志,2020,35(01):127.[doi:10.3969/j.issn.1671-7414.2020.01.033]
PENG Ji-yinga,YANG Hong-jieb,SHI Xiao-xina,et al.Application Value of Fine Needle Aspiration Cytology in Recurrence
Diagnosis of Thyroid Cancer after Iodine-131 Treatment[J].Journal of Modern Laboratory Medicine,2020,35(04):127.[doi:10.3969/j.issn.1671-7414.2020.01.033]
[2]赵芳芳,郭 红,陈 嘉.LncRNA TUG1 在甲状腺癌组织中的表达及其对细胞增殖和迁移的影响[J].现代检验医学杂志,2020,35(06):42.[doi:doi:10.3969/j.issn.1671-7414.2020.06.011]
ZHAO Fang-fang,GUO Hong,CHEN Jia.Expression of LncRNA TUG1 in Thyroid Carcinoma Tissues and Its Effect onCell Proliferation and Migration[J].Journal of Modern Laboratory Medicine,2020,35(04):42.[doi:doi:10.3969/j.issn.1671-7414.2020.06.011]
[3]谈玖婷,傅聿明,刘 婧,等.甲状腺癌组织中DCBLD2 和MAP4K3 的表达及与临床病理特征及预后的关系[J].现代检验医学杂志,2024,39(02):34.[doi:10.3969/j.issn.1671-7414.2024.02.007]
TAN Jiuting,FU Yuming,LIU Jing,et al.Expression of DCBLD2 and MAP4K3 in Thyroid Cancer Tissue and Their Relationship with Clinico-pathological Features and Prognosis[J].Journal of Modern Laboratory Medicine,2024,39(04):34.[doi:10.3969/j.issn.1671-7414.2024.02.007]
[4]张廷华a,胡友元b,袁 博.miR-100-5p 对甲状腺癌细胞增殖与凋亡调控作用的实验研究[J].现代检验医学杂志,2024,39(04):56.[doi:10.3969/j.issn.1671-7414.2024.04.011]
ZHANG Tinghuaa,HU Youyuanb,YUAN Bo.Experimental Study on the Regulatory Effects of miR-100-5p on Proliferation and Apoptosis of Thyroid Cancer Cells[J].Journal of Modern Laboratory Medicine,2024,39(04):56.[doi:10.3969/j.issn.1671-7414.2024.04.011]